NEDD4L inhibited lung adenocarcinoma cell progression in vitro and in vivo via inducing the ubiquitination‐mediated Ubiquitin‐conjugating enzyme E2T (UBE2T) degradation, which repressed PI3K‐Akt signalling.38 This evidence concerns the gene UBE2T and lung adenocarcinoma.